A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness
- PMID: 11338284
- DOI: 10.1034/j.1399-3038.2001.0129999107.x
A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness
Abstract
Hearing loss in patients with X-linked agammaglobulinemia is often attributed to recurrent infections. However, recent genetic studies suggest a different etiology in some patients. We present three unrelated patients, 6, 9, and 14 years of age, with large deletions of the terminal portion of the Bruton tyrosine kinase (Btk) gene extending 4.2-19 kb beyond the 3' end of the gene. The DNA immediately downstream of the 3' end of Btk contains the deafness-dystonia protein gene (DDP). Mutations in this gene have recently been shown to underlie the Mohr-Tranebjaerg syndrome, which is characterized by sensorineural deafness, dystonia, and mental deficiency. Besides the immunodeficiency, our patients exhibited progressive sensorineural deafness. The clue to an associated hearing problem was delayed development of speech in one patient and post-lingual deafness noticed between the age of 3-4 years in the other two. These patients have not yet exhibited significant associated neurologic deficits.
Similar articles
-
Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.Front Immunol. 2020 Sep 4;11:2001. doi: 10.3389/fimmu.2020.02001. eCollection 2020. Front Immunol. 2020. PMID: 33013854 Free PMC article.
-
Focal dystonia caused by Mohr-Tranebjaerg syndrome with complete deletion of the DDP1 gene.Neurology. 2004 Mar 23;62(6):1021-2. doi: 10.1212/01.wnl.0000115174.96423.a8. Neurology. 2004. PMID: 15037720 No abstract available.
-
Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes.J Clin Immunol. 2007 Nov;27(6):640-6. doi: 10.1007/s10875-007-9123-x. Epub 2007 Sep 12. J Clin Immunol. 2007. PMID: 17851739
-
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).Front Biosci. 2000 Dec 1;5:D917-28. doi: 10.2741/vihinen. Front Biosci. 2000. PMID: 11102316 Review.
-
The spectrum of mutations in Btk that cause X-linked agammaglobulinemia.Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 2):S192-7. doi: 10.1016/s0090-1229(95)90198-1. Clin Immunol Immunopathol. 1995. PMID: 7554467 Review. No abstract available.
Cited by
-
Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.Front Immunol. 2020 Sep 4;11:2001. doi: 10.3389/fimmu.2020.02001. eCollection 2020. Front Immunol. 2020. PMID: 33013854 Free PMC article.
-
X-linked Agammaglobulinemia.Indian J Pediatr. 2016 Apr;83(4):331-7. doi: 10.1007/s12098-015-2024-8. Epub 2016 Feb 24. Indian J Pediatr. 2016. PMID: 26909497 Review.
-
Neurodegenerative changes detected by neuroimaging in a patient with contiguous X-chromosome deletion syndrome encompassing BTK and TIMM8A genes.Cent Eur J Immunol. 2018;43(2):139-147. doi: 10.5114/ceji.2018.77383. Epub 2018 Jun 30. Cent Eur J Immunol. 2018. PMID: 30135625 Free PMC article.
-
Otopathology in Mohr-Tranebjaerg syndrome.Laryngoscope. 2007 Jul;117(7):1202-8. doi: 10.1097/MLG.0b013e3180581944. Laryngoscope. 2007. PMID: 17471106 Free PMC article.
-
Familial 5.29 Mb deletion in chromosome Xq22.1-q22.3 with a normal phenotype: a rare pedigree and literature review.BMC Med Genomics. 2023 May 22;16(1):111. doi: 10.1186/s12920-023-01547-2. BMC Med Genomics. 2023. PMID: 37217926 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical